Infantile hereditary spastic paraparesis due to codominant mutations in the spastin gene

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Hereditary spastic paraplegia (HSP) encompasses a group of neurodegenerative disorders.
• Spastic paraplegia type 4 (SPG4) is the most common form of autosomal dominant HSP, primarily caused by mutations in the SPG4 gene, which encodes the spastin protein.
• Spastin plays a crucial role in microtubule dynamics, essential for neuronal function and axonal transport.

Observation:

• This study details a unique case of an infant presenting with severe spastic paraparesis.
• The infant harbored two distinct, codominant mutations within the SPG4 gene.
• This genetic profile deviates from typical SPG4 presentations, suggesting complex inheritance patterns.

Findings:

• The identified codominant mutations in the spastin gene were directly linked to the severe spastic paraparesis phenotype in the infant.
• Analysis revealed that these mutations likely disrupt spastin function through novel molecular mechanisms.
• The findings underscore the genetic heterogeneity and diverse pathological pathways underlying SPG4.

Implications:

• The case highlights that SPG4's molecular pathology can arise from multiple, potentially codominant, genetic mechanisms.
• Complete sequencing of the spastin gene is essential for accurate diagnosis in all individuals with suspected SPG4.
• Identifying unusual phenotypes associated with spastin mutations can broaden our understanding of HSP and guide future diagnostic strategies.